Testosterone Therapy for Low Testosterone and Diabetes

"Yes, clinicaltrials.gov hosts data affirming that this medical research is currently enrolling participants. The trial was initially published on October 1st 2019 and has been recently edited in November 8th 2022. 166 patients are needed to be accepted from a single clinic site."

"This medical trial is seeking 166 volunteers between the ages of 35 and 65 who are diagnosed with type 2 diabetes mellitus. In addition to this, they must possess a plethora of other characteristics including: male gender, 15 years or less duration since diagnosis, A1C below 10.5%, and body mass index (BMI) under 35 kg/m2."

"According to the data hosted on clinicaltrials.gov, this study is presently enrolling participants and was initially publicised on October 1st 2019 before being revised most recently on November 8th 2022."

"Currently, 29 clinical trials are underway for Testosterone gel 1.62%. Of those research studies, 5 have reached the Phase 3 stage of development. Whilst most locations running this trial are in Houston Texas, there is a total of 124 sites across America actively contributing to these experiments."

"There is extensive research and clinical data pointing to the safety of Testosterone gel 1.62%, thus it was assigned a rating of 3 on our team's scale."

"This clinical trial mandates that prospective participants must be between 35 and 65-years-old, as indicated in the study's inclusion criteria."

"Hypogonadotropic hypogonadism can be managed with an application of Testosterone gel 1.62%. In addition, this treatment is also beneficial for women who have gone through menopause within the last 5 years, as well as those dealing with orchidectomy and orchitis."